Fig. 2
From: Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs
A theoretical diagram of the potential cost, effectiveness and cost-effectiveness of a mass drug administration programme before and after elimination. Note that this figure is illustrative and not based on primary data. The time horizon for the cost-effectiveness analysis is the duration over which the outcomes and costs are calculated. Both the cost and effects are being discounted into the future at a rate of 3%